Keywords: Breast, Breast, radiomics, DCE-MRIOur objective is to predict pathological complete response (pCR) outcome to neoadjuvent chemotherapy in breast cancer patients. We combine radiomic features with background parenchymal enhancement -- computed from standard-of DCE-MRI data from the ISPY-2 trial -- and model treatment outcome via multivariable logistic regression. During training and testing, we demonstrate that models including BPE alongside radiomic and clinical covariates yielded the highest AUC values among all tested regression models, thus improving the prediction of pCR outcome.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords